New Releases from NCBI BookshelfSelpercatinib for previously treated RET fusion-positive advanced non-small-cell lung cancer.Selpercatinib for previously treated RET fusion-positive advanced non-small-cell lung cancer.By admin / April 30, 2025 Post Content